Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1986-2-20
|
pubmed:abstractText |
The hereditary dysplastic nevus syndrome (DNS) is a well-characterized disorder in which affected individuals have increased numbers of premalignant (dysplastic) nevi and a markedly increased risk of developing cutaneous melanoma. Seeking evidence of a systemic disorder in DNS, we examined the effect of ultraviolet radiation on cultured lymphoid cells. Epstein-Barr virus-transformed lymphoblastoid cell lines from patients with hereditary DNS had similar survival values following treatment with 2.3 to 9.0 J of 254-nm ultraviolet radiation per m2 as did lines from control individuals. Mutagenesis at the hypoxanthineguanine phosphoribosyltransferase locus was assessed by measuring the induction of resistance to thioguanine using a microtiter well assay. Three lymphoblastoid cell lines from patients with hereditary DNS and melanoma had a 2- to 3-fold greater frequency of induced mutants per clonable cell than three normal lines following exposure to 4.5 to 9.0 J of ultraviolet radiation per m2. Expanded clones of mutated DNS lymphoblastoid cell lines had less than 6% of normal hypoxanthine-guanine phosphoribosyltransferase activity. Inhibition and recovery of DNA synthesis following ultraviolet exposure were similar in 2 DNS and 2 normal lines. Repair by DNS lines of ultraviolet-induced DNA damage was in the normal range as measured by alkaline elution. Thus, hereditary DNS exhibits in vitro hypermutability which may reflect increased susceptibility to ultraviolet-induced somatic mutations in vivo. This abnormality may be related to the increased melanoma susceptibility of patients with hereditary DNS.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1005-9
|
pubmed:dateRevised |
2008-8-12
|
pubmed:meshHeading |
pubmed-meshheading:3940625-Adult,
pubmed-meshheading:3940625-Cell Survival,
pubmed-meshheading:3940625-Cells, Cultured,
pubmed-meshheading:3940625-DNA,
pubmed-meshheading:3940625-DNA Repair,
pubmed-meshheading:3940625-Female,
pubmed-meshheading:3940625-Humans,
pubmed-meshheading:3940625-Hypoxanthine Phosphoribosyltransferase,
pubmed-meshheading:3940625-Lymphocytes,
pubmed-meshheading:3940625-Male,
pubmed-meshheading:3940625-Melanoma,
pubmed-meshheading:3940625-Mutation,
pubmed-meshheading:3940625-Nevus,
pubmed-meshheading:3940625-Ultraviolet Rays
|
pubmed:year |
1986
|
pubmed:articleTitle |
Hereditary dysplastic nevus syndrome: lymphoid cell ultraviolet hypermutability in association with increased melanoma susceptibility.
|
pubmed:publicationType |
Journal Article
|